Department of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta
Department of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta.
BMJ Case Rep. 2021 Mar 4;14(3):e239543. doi: 10.1136/bcr-2020-239543.
A70-year-old man, with established hypoadrenalism due to a previous bilateral adrenalectomy, was admitted with recurrent episodes of postural dizziness and presyncope. He had been discharged from hospital 3 weeks earlier on a 1-month course of cotrimoxazole following a diagnosis of prostatitis. His electrolytes on admission showed new onset hyponatraemia and hyperkalaemia.His usual glucocorticoid replacement dose was doubled in view of a presumed diagnosis of hypocortisolaemia. However, the hyperkalaemia persisted. On rereviewing his treatment, we suspected a possible diagnosis of cotrimoxazole-induced hyperkalaemia. Cotrimoxazole was stopped and ciprofloxacin started instead. His fludrocortisone replacement was doubled for 3 days after stopping treatment to decrease his postural symptoms. His postural symptoms improved, his serum potassium decreased to normal levels and he was safely discharged.It is essential to remember that cotrimoxazole, a commonly used antibiotic, can induce a potentially fatal hyperkalaemia especially in patients with known hypoadrenalism.
一位 70 岁的男性,由于先前的双侧肾上腺切除术而患有明确的肾上腺功能减退症,因反复出现直立性头晕和晕厥前状态而入院。他在 3 周前因前列腺炎被诊断后出院,接受了为期 1 个月的复方新诺明治疗。入院时的电解质检查显示新出现的低钠血症和高钾血症。鉴于疑似皮质醇减少症,他的常规糖皮质激素替代剂量增加了一倍。然而,高钾血症仍然存在。在重新审查他的治疗方案后,我们怀疑可能是复方新诺明引起的高钾血症。停用了复方新诺明,并改用环丙沙星。在停止治疗后,他的氟氢可的松替代剂量增加了两倍,以减少他的直立性症状。他的直立性症状改善,血清钾降低至正常水平,然后安全出院。重要的是要记住,复方新诺明是一种常用的抗生素,可能会导致潜在致命的高钾血症,尤其是在已知患有肾上腺功能减退症的患者中。